trial · primary record
Cytarabine
Acute Myeloid Leukemia
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 107 |
| Primary completion | 2029-07-31 |
| Primary endpoint | Relapse free survival of Cohort A compared to intermediate risk historical control group |
| Registry ID | NCT02756962 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:35:13.554Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02756962
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- CYTARABINE · approval
- Cytarabine · compound